Ketone supplement for alcohol use disorder
Part of Hormones & metabolism, Mental health clinical trials.
This study tests whether a ketone supplement affects how the brain uses energy and whether it can reduce alcohol cravings and drinking. If you drink regularly but aren't looking for treatment, you may be able to join.
Summary written for real people, not researchers, by Clin2.
Who can take part
- Be between 21 and 65 years old.
- Drink at least 15 standard drinks per week on average.
- Not be actively seeking treatment for alcohol use disorder.
- Have no major mental health conditions requiring hospitalization or daily medication in the past year (other than alcohol, marijuana, or nicotine use).
- Have no serious medical conditions like liver disease, diabetes, or epilepsy.
- Be willing to avoid alcohol for 24 hours before study procedures and be able to undergo MRI and PET scans (no metal implants, no claustrophobia).
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests whether a ketone-based treatment (a ketone ester) can change brain activity in people with alcohol use disorder who are not currently seeking treatment. You may also have brain scans, so the study is looking for safe MRI eligibility and certain health factors.
This study tests whether a special ketone drink can ease alcohol withdrawal and help your brain heal. If you have been drinking heavily for at least 3 years and are having withdrawal symptoms now, this might be an option for you.
This study tests whether a special supplement (ketones) can help people feel better during alcohol withdrawal. It is for adults who are already in a treatment program for alcohol withdrawal.
This study tests whether eating a ketogenic diet (very low carb, high fat) changes how your body processes alcohol. Researchers will have you follow a special diet and then measure your body's response to controlled amounts of alcohol in a lab setting.
This trial tests how the medication acamprosate affects brain activity in people with moderate to severe alcohol use disorder. It may help researchers understand how this treatment works.
This study uses a special brain scan (PET) to look at a protein called PDE4B in people with alcohol use disorder. The goal is to better understand how alcohol affects the brain, which may lead to new treatments.
Hear when a new Alcohol Use Disorder trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.